ATE458818T1 - Tet repressor basierte transkriptionale regulatorische proteine - Google Patents
Tet repressor basierte transkriptionale regulatorische proteineInfo
- Publication number
- ATE458818T1 ATE458818T1 AT00938973T AT00938973T ATE458818T1 AT E458818 T1 ATE458818 T1 AT E458818T1 AT 00938973 T AT00938973 T AT 00938973T AT 00938973 T AT00938973 T AT 00938973T AT E458818 T1 ATE458818 T1 AT E458818T1
- Authority
- AT
- Austria
- Prior art keywords
- tetracycline
- transcriptional regulatory
- regulatory proteins
- tet repressor
- based transcriptional
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
- C12N2830/003—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor tet inducible
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
- C12N2830/006—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB tet repressible
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13798699P | 1999-06-07 | 1999-06-07 | |
PCT/IB2000/000886 WO2000075347A2 (en) | 1999-06-07 | 2000-06-05 | Tet repressor-based transcriptional regulatory proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE458818T1 true ATE458818T1 (de) | 2010-03-15 |
Family
ID=22479925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00938973T ATE458818T1 (de) | 1999-06-07 | 2000-06-05 | Tet repressor basierte transkriptionale regulatorische proteine |
Country Status (8)
Country | Link |
---|---|
US (1) | US7541446B2 (de) |
EP (1) | EP1200607B1 (de) |
JP (1) | JP4836375B2 (de) |
AT (1) | ATE458818T1 (de) |
AU (1) | AU783233B2 (de) |
CA (1) | CA2376665C (de) |
DE (1) | DE60043889D1 (de) |
WO (1) | WO2000075347A2 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030186281A1 (en) * | 2001-12-21 | 2003-10-02 | Wolfgang Hillen | Modified tetracycline repressor protein compositions and methods of use |
US8507277B2 (en) | 2003-10-24 | 2013-08-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides |
US8062891B2 (en) | 2003-10-24 | 2011-11-22 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to plants |
EP2418281B1 (de) | 2003-10-24 | 2016-06-01 | Gencia Corporation | Verfahren und Zusammensetzungen zur Abgabe von Polynukleotiden |
US8133733B2 (en) | 2003-10-24 | 2012-03-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to target tissues |
US20090123468A1 (en) | 2003-10-24 | 2009-05-14 | Gencia Corporation | Transducible polypeptides for modifying metabolism |
US7935788B2 (en) * | 2004-10-04 | 2011-05-03 | National Research Council Of Canada | Reverse cumate repressor mutant |
WO2006037215A1 (en) * | 2004-10-04 | 2006-04-13 | National Research Council Of Canada | Expression system, components thereof and methods of use |
US9068969B2 (en) * | 2004-12-28 | 2015-06-30 | Ptc Therapeutics, Inc. | Cell based methods and systems for the identification of RNA regulatory sequences and compounds that modulate their functions |
JP4944781B2 (ja) | 2005-09-15 | 2012-06-06 | 独立行政法人科学技術振興機構 | テトラサイクリン系抗生物質によるタンパク質分解制御法 |
USRE49583E1 (en) | 2005-11-17 | 2023-07-18 | Tet Systems Gmbh & Co. Kg | Inducible expression systems |
EP2537934A3 (de) * | 2006-05-15 | 2013-04-10 | Paratek Pharmaceuticals, Inc. | Verfahren zur Regelung der Genexpression oder von Genprodukten mit substituierten Tetracyclinverbindungen |
RU2468820C2 (ru) * | 2006-07-26 | 2012-12-10 | Интрексон Корпорейшн | Способы и композиции для лечения заболевания |
JP5126907B2 (ja) * | 2007-03-14 | 2013-01-23 | 独立行政法人科学技術振興機構 | 抗生物質によるタンパク質の転写・分解二重制御法 |
US20080235746A1 (en) | 2007-03-20 | 2008-09-25 | Michael James Peters | Methods and apparatus for content delivery and replacement in a network |
EP2352833B1 (de) | 2008-10-01 | 2013-03-06 | TET Systems GmbH & Co. KG | Tetracyclin-induzierbare transkriptionskontrollsequenz |
MX2011003766A (es) | 2008-10-28 | 2011-04-27 | Pioneer Hi Bred Int | Proteinas represoras responsivas a sulfonilurea. |
US9866609B2 (en) | 2009-06-08 | 2018-01-09 | Time Warner Cable Enterprises Llc | Methods and apparatus for premises content distribution |
EP2560473A1 (de) * | 2010-04-23 | 2013-02-27 | Pioneer Hi-Bred International Inc. | Genschalterzusammensetzungen und verfahren zu ihrer verwendung |
JP6022470B2 (ja) | 2010-11-24 | 2016-11-09 | タカラ バイオ ユーエスエー, インコーポレイテッド | 分散型タンパク質形質導入ドメインを含む誘導性発現系転写モジュレータおよびその使用方法 |
US20120190107A1 (en) * | 2011-01-26 | 2012-07-26 | Dwayne Bisgrove | Enhanced protein transduction |
EP2710130B1 (de) | 2011-05-19 | 2022-06-29 | Fundación Pública Andaluza Progreso Y Salud | Effizient induzierbare lentivirale tet-on-vektor system mit zwei-promotoren |
WO2017036565A1 (en) | 2015-09-04 | 2017-03-09 | Universita' Degli Studi Di Padova | Method for generating somatic stem cells |
MA45489A (fr) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | Procédés de culture de cellules, kits et appareil associés |
CA3025423A1 (en) | 2016-05-27 | 2017-11-30 | Synthex, Inc. | Protein interfaces |
US10687115B2 (en) | 2016-06-01 | 2020-06-16 | Time Warner Cable Enterprises Llc | Cloud-based digital content recorder apparatus and methods |
US10129593B2 (en) | 2017-03-14 | 2018-11-13 | Charter Communications Operating, Llc | Time-based dynamic secondary content placement calls in time-shifted content |
KR102606210B1 (ko) | 2017-04-27 | 2023-11-24 | 주노 테라퓨틱스 게엠베하 | 올리고머 입자 시약 및 이의 사용 방법 |
WO2019104244A1 (en) | 2017-11-22 | 2019-05-31 | Synthex, Inc. | Peptides for inhibiting rad51 |
US10939142B2 (en) | 2018-02-27 | 2021-03-02 | Charter Communications Operating, Llc | Apparatus and methods for content storage, distribution and security within a content distribution network |
CN113584083A (zh) | 2020-04-30 | 2021-11-02 | 深圳市深研生物科技有限公司 | 用于逆转录病毒载体的生产细胞和包装细胞及其制备方法 |
CN113699147B (zh) | 2020-05-22 | 2023-06-09 | 深圳市深研生物科技有限公司 | 基于四环素和Cumate的共调控序列 |
US11566262B2 (en) | 2021-03-24 | 2023-01-31 | Dna Twopointo Inc. | Tetracycline-inducible expression systems |
CN114134160B (zh) * | 2021-12-04 | 2024-01-09 | 安徽大学 | 一种四环素调控蛋白突变体基因及其在调控基因表达和环境检测中的应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU683227B2 (en) * | 1992-08-26 | 1997-11-06 | Bioscience 2002 Llc | Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic animals |
US5866755A (en) * | 1993-06-14 | 1999-02-02 | Basf Aktiengellschaft | Animals transgenic for a tetracycline-regulated transcriptional inhibitor |
US5650298A (en) * | 1993-06-14 | 1997-07-22 | Basf Aktiengesellschaft | Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
US6004941A (en) * | 1993-06-14 | 1999-12-21 | Basf Aktiengesellschaft | Methods for regulating gene expression |
US5464758A (en) * | 1993-06-14 | 1995-11-07 | Gossen; Manfred | Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
US5589362A (en) * | 1993-06-14 | 1996-12-31 | Basf Aktiengesellschaft | Tetracycline regulated transcriptional modulators with altered DNA binding specificities |
DE4417598A1 (de) * | 1994-05-19 | 1995-12-14 | Max Planck Gesellschaft | Verwendung des Tetracyclinpromotors zur stringent regulierten Produktion von rekombinanten Proteinen in prokaryontischen Zellen |
US5851796A (en) * | 1995-06-07 | 1998-12-22 | Yale University | Autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes |
US6114148C1 (en) * | 1996-09-20 | 2012-05-01 | Gen Hospital Corp | High level expression of proteins |
US6087166A (en) * | 1997-07-03 | 2000-07-11 | Basf Aktiengesellschaft | Transcriptional activators with graded transactivation potential |
DE19851413C2 (de) | 1998-11-07 | 2003-05-22 | Wolfgang Hillen | Verfahren zur Auswahl von Mutanten von tTA oder rtTA |
DE19851415B4 (de) | 1998-11-07 | 2010-11-04 | Wolfgang Hillen | Mutanter Transaktivator |
-
2000
- 2000-06-05 DE DE60043889T patent/DE60043889D1/de not_active Expired - Fee Related
- 2000-06-05 EP EP00938973A patent/EP1200607B1/de not_active Expired - Lifetime
- 2000-06-05 AU AU54191/00A patent/AU783233B2/en not_active Expired
- 2000-06-05 CA CA2376665A patent/CA2376665C/en not_active Expired - Lifetime
- 2000-06-05 JP JP2001501629A patent/JP4836375B2/ja not_active Expired - Lifetime
- 2000-06-05 WO PCT/IB2000/000886 patent/WO2000075347A2/en active IP Right Grant
- 2000-06-05 AT AT00938973T patent/ATE458818T1/de not_active IP Right Cessation
-
2003
- 2003-06-05 US US10/456,395 patent/US7541446B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1200607A2 (de) | 2002-05-02 |
AU783233B2 (en) | 2005-10-06 |
CA2376665A1 (en) | 2000-12-14 |
CA2376665C (en) | 2014-02-25 |
WO2000075347A2 (en) | 2000-12-14 |
EP1200607B1 (de) | 2010-02-24 |
US20030208783A1 (en) | 2003-11-06 |
JP4836375B2 (ja) | 2011-12-14 |
JP2003515314A (ja) | 2003-05-07 |
US7541446B2 (en) | 2009-06-02 |
DE60043889D1 (en) | 2010-04-08 |
WO2000075347A3 (en) | 2002-01-10 |
AU5419100A (en) | 2000-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE458818T1 (de) | Tet repressor basierte transkriptionale regulatorische proteine | |
ATE280160T1 (de) | Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität | |
ATE311363T1 (de) | Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren | |
ATE233274T1 (de) | Oxyiminopregnancarbolactone | |
DK0876330T3 (da) | Aryl- eller heteroarylamider af tetrahydronapthylen-, chroman-, thiochroman- og 1,2,3,4-tetrahydroquinolincarboxylsyrer, som har retinoidlignende biologisk aktivitet | |
DK0515544T3 (da) | Steroidsulfataseinhibitorer | |
PT1165115E (pt) | Modulacao da permeabilidade vascular por meio dos activadores do receptor tie2 | |
DE60035032D1 (de) | Verwendung von pioglitazone zur verbesserung der ketose und der azidose | |
DE69110771T2 (de) | Stahlkabel zur Verstärkung von elastomeren Erzeugnissen. | |
DK1200418T3 (da) | Nematodicide trifluorbutener | |
ATE167476T1 (de) | Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel. | |
DE59803538D1 (de) | Wässerige dispersionen enthaltend polyurethane mit carbodiimidgruppen | |
IT1285770B1 (it) | Composti corticoidei | |
ATE190352T1 (de) | Dorsalgewebe beeinflussender faktor und zusammensetzungen | |
DE69609864D1 (de) | Steroidnitritesterderivate und ihre verwendung als entzündungshemmende medikamente | |
ATE226254T1 (de) | Reagenz zur behandlung von arthritischen zustaenden | |
ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
DK0652964T3 (da) | Promotor af K. lactis transaldolasegenet og anvendelse heraf | |
DE60231137D1 (de) | Reca-negativ und rhab-negativ mikroorganismus | |
DK0633928T3 (da) | Mikroorganismer, deres fremstilling og anvendelse | |
HUP0202852A2 (hu) | Módosított ubiquitin-szabályozó rendszer | |
ATE165594T1 (de) | Triarylethylenderivate zur therapeutischen verwendung | |
ATE249230T1 (de) | Selektion und verwendung von milchsäurebakterienstämmen, die die nicht- spezifische immunität modulieren können | |
TR200400907T4 (tr) | Beta D 5-Tiyoksiloz türevleri, bunları hazırlama yöntemi ve bunların terapötik kullanımları | |
DE69016693T2 (de) | Züchtung von transformierten Mikroorganismen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |